Ascendis Pharma A/S
ASND
Hisse Senetlerindeki Sıralama
#1507
Ascendis Pharma A/S is a biopharmaceutical enterprise dedicated to advancing... Ascendis Pharma A/S is a biopharmaceutical enterprise dedicated to advancing therapeutic solutions for critical medical conditions that currently lack effective treatments. Its commercialized offering is SKYTROFA, a therapy prescribed for individuals suffering from growth hormone deficiency (GHD). The company boasts a robust development pipeline, featuring several TransCon-branded candidates. These include TransCon Growth Hormone (hGH), which is being progressed for pediatric GHD patients in Japan and for adults with GHD. Also under development are TransCon parathyroid hormone for adults with hypoparathyroidism, and TransCon CNP, aimed at treating pediatric achondroplasia. Further expanding its innovative portfolio, Ascendis is also developing a TransCon toll-like receptor (TLR) 7/8 agonist for intratumoral administration, alongside TransCon IL-2 ß/g, designed for systemic delivery. Founded in 2006, this enterprise maintains its corporate headquarters in Hellerup, Denmark.
Hisse Fiyatı
$230.45
Son senkronizasyon: 2026-10-19
Piyasa Değeri
$14.37B
Değişim (1 gün)
2.31%
Değişim (1 yıl)
12.30%
Ülke
DK
Ticaret Ascendis Pharma A/S (ASND)
Kategori
Healthcare
Ascendis Pharma A/S (ASND) için P/S oranı
October 2026 itibarıyla P/S oranı TTM: 11.93
Ascendis Pharma A/S şirketinin en son mali raporları ve hisse fiyatına göre, mevcut P/S oranı (TTM) 11.93'dir. 2023 yılının sonunda şirketin P/S oranı 24.05 idi.
Ascendis Pharma A/S için P/S oranı geçmişi 2011 - 2026 arası
Her yılın sonunda P/S oranı
| Yıl | P/S Oranı | Değiştir |
|---|---|---|
| 2026 (TTM) | 11.93 | -43.64% |
| 2024 | 21.17 | -11.98% |
| 2023 | 24.05 | -80.76% |
| 2022 | 124.97 | -85.00% |
| 2021 | 833.09 | -16.14% |
| 2020 | 993.40 | 130.30% |
| 2019 | 431.35 | 103.35% |
| 2018 | 212.13 | -70.89% |
| 2017 | 728.64 | 557.34% |
| 2016 | 110.85 | 125.22% |
| 2015 | 49.22 | 161.17% |
| 2014 | 18.84 | 160.08% |
| 2013 | 7.25 | -26.75% |
| 2012 | 9.89 | 0.00% |
| 2011 | 0.00 | 0.00% |
Benzer şirketler veya rakipler için P/S oranı
| Şirket | P/S Oranı | P/S Oranı Farkı | Ülke |
|---|---|---|---|
| 10.02 | -16.00% |
US
|
|
| 40.55 | 239.89% |
US
|
|
| 3.96 | -66.80% |
AU
|
|
| - | - |
CH
|
|
| 10.15 | -14.96% |
NL
|
